{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:28:58Z","timestamp":1793860138246,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2026-1049"],"award-info":[{"award-number":["ORF-2026-1049"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11636-w","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:14:20Z","timestamp":1782396860000},"page":"9689-9706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thiazolidinedione-triazole hybrids: design, synthesis, and biological evaluation as dual inhibitors of \u03b1-amylase and aldose reductase with antioxidant activity for antidiabetic therapy"],"prefix":"10.1007","volume":"30","author":[{"given":"Eman E.","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R.","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed Nasser Eid","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa I","family":"Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel S.","family":"El-Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem A.","family":"Ghabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A.- M.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"17","key":"11636_CR1","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Mart\u00edn C (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21(17):6275","journal-title":"Int J Mol Sci"},{"issue":"14","key":"11636_CR2","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.3390\/ijms22147644","volume":"22","author":"L Dilworth","year":"2021","unstructured":"Dilworth L, Facey A, Omoruyi F (2021) Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int J Mol Sci 22(14):7644","journal-title":"Int J Mol Sci"},{"issue":"9","key":"11636_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2174\/1389201025666230830125147","volume":"25","author":"JK Gupta","year":"2024","unstructured":"Gupta JK (2024) The role of aldose reductase in polyol pathway: an emerging pharmacological target in diabetic complications and associated morbidities. Curr Pharm Biotechnol 25(9):1073\u20131081","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"11636_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2174\/092986709787458362","volume":"16","author":"P Alexiou","year":"2009","unstructured":"Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ (2009) Aldose reductase enzyme and its implication to major health problems of the 21st century. Curr Med Chem 16(6):734\u2013752","journal-title":"Curr Med Chem"},{"issue":"5","key":"11636_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0002-9343(85)90504-2","volume":"79","author":"PF Kador","year":"1985","unstructured":"Kador PF, Kinoshita JH (1985) Role of aldose reductase in the development of diabetes-associated complications. Am J Med 79(5):8\u201312","journal-title":"Am J Med"},{"issue":"7","key":"11636_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s12272-021-01343-5","volume":"44","author":"S Thakur","year":"2021","unstructured":"Thakur S, Gupta SK, Ali V, Singh P, Verma M (2021) Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. Arch Pharm Res 44(7):655\u2013667","journal-title":"Arch Pharm Res"},{"issue":"4","key":"11636_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/biomedicines12040747","volume":"12","author":"A-I D\u0103nil\u0103","year":"2024","unstructured":"D\u0103nil\u0103 A-I, Ghenciu LA, Stoicescu ER, Bolintineanu SL, Iacob R, S\u0103ndesc M-A, Faur AC (2024) Aldose reductase as a key target in the prevention and treatment of diabetic retinopathy: a comprehensive review. Biomedicines 12(4):747","journal-title":"Biomedicines"},{"issue":"16","key":"11636_CR8","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.3390\/plants12162944","volume":"12","author":"H Kashtoh","year":"2023","unstructured":"Kashtoh H, Baek K-H (2023) New insights into the latest advancement in \u03b1-amylase inhibitors of plant origin with anti-diabetic effects. Plants 12(16):2944","journal-title":"Plants"},{"issue":"7\u20138","key":"11636_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/star.201200194","volume":"65","author":"S Jayaraj","year":"2013","unstructured":"Jayaraj S, Suresh S, Kadeppagari RK (2013) Amylase inhibitors and their biomedical applications. Starch\/St\u00e4rke 65(7\u20138):535\u2013542","journal-title":"Starch\/St\u00e4rke"},{"issue":"5","key":"11636_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1592\/phco.28.5.646","volume":"28","author":"MA Ramirez","year":"2008","unstructured":"Ramirez MA, Borja NL (2008) Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy 28(5):646\u2013655","journal-title":"Pharmacotherapy"},{"issue":"5","key":"11636_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jdiacomp.2009.07.005","volume":"24","author":"KE Schemmel","year":"2010","unstructured":"Schemmel KE, Padiyara RS, D\u2019Souza JJ (2010) Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complicat 24(5):354\u2013360","journal-title":"J Diabetes Complicat"},{"key":"11636_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2017.00006","volume":"8","author":"A Chaudhury","year":"2017","unstructured":"Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, Marco A, Shekhawat NS, Montales MT, Kuriakose K (2017) Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol 8:6","journal-title":"Front Endocrinol"},{"key":"11636_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejmech.2017.02.031","volume":"129","author":"MJ Naim","year":"2017","unstructured":"Naim MJ, Alam MJ, Ahmad S, Nawaz F, Shrivastava N, Sahu M, Alam O (2017) Therapeutic journey of 2, 4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship. Eur J Med Chem 129:218\u2013250","journal-title":"Eur J Med Chem"},{"issue":"3","key":"11636_CR14","first-page":"137","volume":"2","author":"H Mucke","year":"2014","unstructured":"Mucke H, Mucke E, Mucke P (2014) Aldose reductase inhibitors for diabetic cataract: A study of disclosure patterns in patents and peer review papers. Ophthalmol Res : Int J 2(3):137\u2013149","journal-title":"Ophthalmol Res : Int J"},{"issue":"4","key":"11636_CR15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0968-0896(01)00366-2","volume":"10","author":"G Bruno","year":"2002","unstructured":"Bruno G, Costantino L, Curinga C, Maccari R, Monforte F, Nicol\u00f2 F, Ottana R, Vigorita M (2002) Synthesis and aldose reductase inhibitory activity of 5-arylidene-2, 4-thiazolidinediones. Bioorg med chem 10(4):1077\u20131084","journal-title":"Bioorg med chem"},{"issue":"11","key":"11636_CR16","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.bmc.2010.04.016","volume":"18","author":"R Maccari","year":"2010","unstructured":"Maccari R, Ciurleo R, Giglio M, Cappiello M, Moschini R, Del Corso A, Mura U, Ottan\u00e0 R (2010) Identification of new non-carboxylic acid containing inhibitors of aldose reductase. Bioorg med chem 18(11):4049\u20134055","journal-title":"Bioorg med chem"},{"key":"11636_CR17","doi-asserted-by":"publisher","first-page":"113630","DOI":"10.1016\/j.ejmech.2021.113630","volume":"223","author":"MUM Siddique","year":"2021","unstructured":"Siddique MUM, Thakur A, Shilkar D, Yasmin S, Halakova D, Kovacikova L, Prnova MS, Stefek M, Acevedo O, Dasararaju G (2021) Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives. Eur j med chem 223:113630","journal-title":"Eur j med chem"},{"key":"11636_CR18","doi-asserted-by":"publisher","first-page":"127487","DOI":"10.1016\/j.molliq.2025.127487","volume":"426","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131 FS, Demir Y, \u015eenol H, Ate\u015fo\u011flu \u015e, Tokal\u0131 P, \u00c7ak\u0131r F, Akba\u015f F (2025) Aldose reductase inhibition properties of novel thiazolidin-2, 4-diones: in vitro and in Silico approach for the treatment of diabetes-related complications. J Mol Liq 426:127487","journal-title":"J Mol Liq"},{"issue":"1","key":"11636_CR19","doi-asserted-by":"publisher","first-page":"2231170","DOI":"10.1080\/14756366.2023.2231170","volume":"38","author":"A Hamdi","year":"2023","unstructured":"Hamdi A, Yaseen M, Ewes WA, Bhat MA, Ziedan NI, El-Shafey HW, Mohamed AA, Elnagar MR, Haikal A, Othman DI (2023) Development of new thiazolidine-2, 4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. J Enzyme Inhib Med Chem 38(1):2231170","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"9","key":"11636_CR20","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/slct.202004362","volume":"6","author":"CH Rathod","year":"2021","unstructured":"Rathod CH, Nariya PB, Maliwal D, Pissurlenkar RR, Kapuriya NP, Patel AS (2021) Design, synthesis and antidiabetic activity of biphenylcarbonitrile-thiazolidinedione conjugates as potential \u03b1\u2010amylase inhibitors. ChemistrySelect 6(9):2464\u20132469","journal-title":"ChemistrySelect"},{"key":"11636_CR21","doi-asserted-by":"publisher","first-page":"116139","DOI":"10.1016\/j.ejmech.2024.116139","volume":"266","author":"G Singh","year":"2024","unstructured":"Singh G, Singh R, Monga V, Mehan S (2024) 3, 5-Disubstituted-thiazolidine-2, 4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation. Eur J Med Chem 266:116139","journal-title":"Eur J Med Chem"},{"key":"11636_CR22","doi-asserted-by":"publisher","first-page":"118569","DOI":"10.1016\/j.bmc.2026.118569","volume":"135","author":"MM Al-Sanea","year":"2026","unstructured":"Al-Sanea MM, Elnagar MR, Mohamed AA, El-Shafey HW, El-Halaby LO, Tawfik SS, Zara S, Balaha M, Elgazar AA, Bukhari SN, Hamdi A (2026) Thiazolidinedione-based dual inhibitors of \u03b1-amylase and aldose reductase: Design, in vitro evaluation, and in vivo hypoglycemic activity. Bioorg med chem 135:118569","journal-title":"Bioorg med chem"},{"issue":"10","key":"11636_CR23","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","volume":"22","author":"E Bonandi","year":"2017","unstructured":"Bonandi E, Christodoulou MS, Fumagalli G, Perdicchia D, Rastelli G, Passarella D (2017) The 1,2,3-triazole ring as a bioisostere in medicinal chemistry. Drug Discov Today 22(10):1572\u20131581","journal-title":"Drug Discov Today"},{"issue":"3","key":"11636_CR24","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s11030-023-10674-y","volume":"28","author":"N Patnam","year":"2024","unstructured":"Patnam N, Chevula K, Chennamsetti P, Aleti B, Kotha AK, Manga V (2024) Synthesis, antidiabetic activity and molecular docking studies of novel aryl benzylidenethiazolidine-2, 4-dione based 1, 2, 3-triazoles. Mol Divers 28(3):1551\u20131563","journal-title":"Mol Divers"},{"key":"11636_CR25","doi-asserted-by":"publisher","first-page":"132613","DOI":"10.1016\/j.molstruc.2022.132613","volume":"1257","author":"DA Anil","year":"2022","unstructured":"Anil DA, Aydin BO, Demir Y, Turkmenoglu B (2022) Design, synthesis, biological evaluation and molecular docking studies of novel 1H-1 2,3-Triazole derivatives as potent inhibitors of carbonic anhydrase, acetylcholinesterase and aldose reductase. J Mol Struct 1257:132613","journal-title":"J Mol Struct"},{"issue":"9","key":"11636_CR26","first-page":"2000090","volume":"353","author":"L Deswal","year":"2020","unstructured":"Deswal L, Verma V, Kumar D, Kaushik CP, Kumar A, Deswal Y, Punia S (2020) Synthesis and antidiabetic evaluation of benzimidazole-tethered 1,2,3\u2010triazoles, Arch. Pharm 353(9):2000090","journal-title":"Pharm"},{"issue":"3","key":"11636_CR27","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11164-022-04921-4","volume":"49","author":"L Deswal","year":"2023","unstructured":"Deswal L, Verma V, Kirar JS, Kumar D, Deswal Y, Kumar A, Bhatia M (2023) Benzimidazole-1,2,3-triazole-piperazine hybrids: design, synthesis, antidiabetic evaluation and molecular modelling studies. Res Chem Intermed 49(3):1059\u20131083","journal-title":"Res Chem Intermed"},{"issue":"5","key":"11636_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/01480545.2023.2262164","volume":"47","author":"A Kaya","year":"2024","unstructured":"Kaya A, Ceylan AF, Kavutcu M, Santamaria A, \u0160olt\u00e9sov\u00e1 Prnov\u00e1 M, Stefek M, Karasu \u00c7 (2024) A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose-and streptozotocin-induced rats: comparison with antioxidant stobadine. Drug Chem Toxicol 47(5):710\u2013720","journal-title":"Drug Chem Toxicol"},{"issue":"21","key":"11636_CR29","doi-asserted-by":"publisher","first-page":"7756","DOI":"10.1021\/jm101008m","volume":"53","author":"P Alexiou","year":"2010","unstructured":"Alexiou P, Demopoulos VJ (2010) A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity. J Med Chem 53(21):7756\u20137766","journal-title":"J Med Chem"},{"key":"11636_CR30","doi-asserted-by":"crossref","unstructured":"Artasensi A, Pedretti A, Vistoli G, Fumagalli L (2020) Type 2 diabetes mellitus: a review of multi-target drugs, Molecules 25 (8) 1987","DOI":"10.3390\/molecules25081987"},{"key":"11636_CR31","doi-asserted-by":"crossref","unstructured":"Julius A, Renuka RR, Hopper W, Babu Raghu P, Rajendran S, Srinivasan S, Dharmalingam K, Alanazi AM, Arokiyaraj S, Prasath S (2022) Inhibition of aldose reductase by novel phytocompounds: A heuristic approach to treating diabetic retinopathy, Evid.-Based Complementary Altern. Med. (1) (2022) 9624118","DOI":"10.1155\/2022\/9624118"},{"issue":"12","key":"11636_CR32","doi-asserted-by":"publisher","first-page":"e202500110","DOI":"10.1002\/open.202500110","volume":"14","author":"MS Khan","year":"2025","unstructured":"Khan MS, Yadav DK, Shahwan M, Shamsi A (2025) Structure-Guided Identification and Evaluation of Epalrestat and Ranirestat\u2010Like Compounds Against Aldose Reductase: Therapeutic Management of Diabetic Neuropathy. ChemistryOpen 14(12):e202500110","journal-title":"ChemistryOpen"},{"issue":"10","key":"11636_CR33","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","volume":"67","author":"Q Guan","year":"2024","unstructured":"Guan Q, Xing S, Wang L, Zhu J, Guo C, Xu C, Zhao Q, Wu Y, Chen Y, Sun H (2024) Triazoles in medicinal chemistry: physicochemical properties, bioisosterism, and application. J Med Chem 67(10):7788\u20137824","journal-title":"J Med Chem"},{"issue":"10","key":"11636_CR34","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0968-0896(98)00139-4","volume":"6","author":"YS Lee","year":"1998","unstructured":"Lee YS, Chen Z, Kador PF (1998) Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase. Bioorg med chem 6(10):1811\u20131819","journal-title":"Bioorg med chem"},{"key":"11636_CR35","doi-asserted-by":"publisher","first-page":"114922","DOI":"10.1016\/j.ejmech.2022.114922","volume":"246","author":"M Kratky","year":"2023","unstructured":"Kratky M, Sramel P, Bodo P, Prnova MS, Kovacikova L, Majekova M, Vinsova J, Stefek M (2023) Novel rhodanine based inhibitors of aldose reductase of non-acidic nature with p-hydroxybenzylidene functional group. Eur J Med Chem 246:114922","journal-title":"Eur J Med Chem"},{"issue":"22","key":"11636_CR36","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.febslet.2013.09.031","volume":"587","author":"L Zhang","year":"2013","unstructured":"Zhang L, Zhang H, Zhao Y, Li Z, Chen S, Zhai J, Chen Y, Xie W, Wang Z, Li Q (2013) Inhibitor selectivity between aldo\u2013keto reductase superfamily members AKR1B10 and AKR1B1: Role of Trp112 (Trp111). FEBS Lett 587(22):3681\u20133686","journal-title":"FEBS Lett"},{"issue":"16","key":"11636_CR37","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1021\/bi9921182","volume":"39","author":"GD Brayer","year":"2000","unstructured":"Brayer GD, Sidhu G, Maurus R, Rydberg EH, Braun C, Wang Y, Nguyen NT, Overall CM, Withers SG (2000) Subsite mapping of the human pancreatic \u03b1-amylase active site through structural, kinetic, and mutagenesis techniques. Biochemistry 39(16):4778\u20134791","journal-title":"Biochemistry"},{"issue":"54","key":"11636_CR38","doi-asserted-by":"publisher","first-page":"39977","DOI":"10.1039\/D4RA07367C","volume":"14","author":"MM Elsebaei","year":"2024","unstructured":"Elsebaei MM, Ezzat HG, Helal AM, El-Shershaby MH, Abdulrahman MS, Alsedawy M, Aljohani AK, Almaghrabi M, Alsulaimany M, Almohaywi B (2024) Rational design and synthesis of novel phenyltriazole derivatives targeting MRSA cell wall biosynthesis. RSC Adv 14(54):39977\u201339994","journal-title":"RSC Adv"},{"issue":"1\u20133","key":"11636_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molstruc.2008.05.028","volume":"892","author":"V Kamalraj","year":"2008","unstructured":"Kamalraj V, Senthil S, Kannan P (2008) One-pot synthesis and the fluorescent behavior of 4-acetyl-5-methyl-1, 2, 3-triazole regioisomers. J Mol Struct 892(1\u20133):210\u2013215","journal-title":"J Mol Struct"},{"issue":"7","key":"11636_CR40","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10593-014-1559-3","volume":"50","author":"A Bunev","year":"2014","unstructured":"Bunev A, Trushkova YO, Ostapenko G, Statsyuk V, Peregudov A (2014) Synthesis of 4-(1 \u041d-1,2,3-Triazol-4-Yl)-1,3-Thiazole-2-Amine Derivatives. Chem Heterocycl Compd 50(7):1027\u20131031","journal-title":"Chem Heterocycl Compd"},{"issue":"1","key":"11636_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11814-016-0234-z","volume":"34","author":"D-S You","year":"2017","unstructured":"You D-S, Lee YW, Choi D, Chang Y-C, Cho H (2017) Algicidal effects of thiazolinedione derivatives against Microcystis aeruginosa. Korean J Chem Eng 34(1):139\u2013149","journal-title":"Korean J Chem Eng"},{"key":"11636_CR42","doi-asserted-by":"publisher","first-page":"108295","DOI":"10.1016\/j.bioorg.2025.108295","volume":"157","author":"AM Almatary","year":"2025","unstructured":"Almatary AM, Al-Sanea MM, Nasr EE, Haikal A, Thompson GS, Abood A, Ibrahim MA, Elgazar AA, Hamdi A (2025) Triazole-linked thiazolidinedione-Benzothiazole hybrids: Design and biological evaluation as AChE inhibitors. Bioorg chem 157:108295","journal-title":"Bioorg chem"},{"key":"11636_CR43","doi-asserted-by":"crossref","unstructured":"Al-Sanea MM, Elnagar MR, Mohamed AA, El-Shafey HW, El-Halaby LO, Tawfik SS, Zara S, Balaha M, Elgazar AA, Bukhari SN (2026) Thiazolidinedione-based dual inhibitors of \u03b1-amylase and aldose reductase: Design, in vitro evaluation, and in vivo hypoglycemic activity. Bioorg Med Chem 118569","DOI":"10.1016\/j.bmc.2026.118569"},{"key":"11636_CR44","doi-asserted-by":"publisher","first-page":"107666","DOI":"10.1016\/j.bioorg.2024.107666","volume":"151","author":"GE Said","year":"2024","unstructured":"Said GE, Metwally HM, Abdel-Latif E, Elnagar MR, Ibrahim HS, Ibrahim MA (2024) Development of non-acidic 4-methylbenzenesulfonate-based aldose reductase inhibitors; Design, Synthesis, Biological evaluation and in-silico studies. Bioorg Chem 151:107666","journal-title":"Bioorg Chem"},{"issue":"45","key":"11636_CR45","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118(45):11225\u201311236","journal-title":"J Am Chem Soc"},{"key":"11636_CR46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejmech.2018.11.004","volume":"162","author":"M Brindisi","year":"2019","unstructured":"Brindisi M, Ulivieri C, Alfano G, Gemma S, de Asis Balaguer F, Khan T, Grillo A, Chemi G, Menchon G, Prota AE (2019) Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents. Eur J Med Chem 162:290\u2013320","journal-title":"Eur J Med Chem"},{"key":"11636_CR47","doi-asserted-by":"publisher","first-page":"13806","DOI":"10.33263\/BRIAC116.1380613828","volume":"11","author":"SA Sakib","year":"2021","unstructured":"Sakib SA, Khan MF, Arman M, Kader FB, Faruk MO, Tanzil SM, Brogi S (2021) Computer-based approaches for determining the pharmacological profile of 5-(3-nitro-arylidene)-thiazolidine-2, 4-dione. Biointerface Res Appl Chem 11:13806\u201313828","journal-title":"Biointerface Res Appl Chem"},{"issue":"3","key":"11636_CR48","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11030-023-10650-6","volume":"28","author":"B Yazdani","year":"2024","unstructured":"Yazdani B, Sirous H, Enguita FJ, Brogi S, Wing PA, Fassihi A (2024) Discovery of novel direct small-molecule inhibitors targeting HIF-2\u03b1 using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations. Mol Diversity 28(3):1203\u20131224","journal-title":"Mol Diversity"},{"issue":"27","key":"11636_CR49","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1021\/j100078a035","volume":"98","author":"DD Humphreys","year":"1994","unstructured":"Humphreys DD, Friesner RA, Berne BJ (1994) A multiple-time-step molecular dynamics algorithm for macromolecules. J Phys Chem 98(27):6885\u20136892","journal-title":"J Phys Chem"},{"issue":"3","key":"11636_CR50","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover WG (1985) Canonical dynamics: Equilibrium phase-space distributions. Phys Rev A 31(3):1695","journal-title":"Phys Rev A"},{"issue":"4177","key":"11636_CR51","first-page":"101063","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna GJ, Tobias DJ, Klein ML (1994) Constant pressure molecular dynamics algorithms. J chem Phys 101(4177):101063","journal-title":"J chem Phys"},{"issue":"19","key":"11636_CR52","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103(19):8577\u20138593","journal-title":"J Chem Phys"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11636-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11636-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11636-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:03:11Z","timestamp":1793858591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11636-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11636"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11636-w","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}